Advanced Cell Therapeutics Ltd. (ACT) is a biotech company specializing in providing safe, easy and ethical access to the latest in Stem Cell Therapies.

All stem cell lines are derived from human umbilical cord blood and have been third party tested for type, count, viability, purity and safety in accordance with the international standards.

ACT utilizes proprietary protocols to generate purified Cord Blood Stem Cells lines. These protocols have been used safely and effectively over the last 4 years in over 700 treatments in over 80 different conditions.

ACT specialises in Multiple Sclerosis research. Based on the premise that the human body is a regenerative entity, it is our mission to provide:
  • access to safe and ethical treatments which target the causes as well as the symptoms of degenerative disease and aging.
  • access to the latest in research and therapeutic application in this emerging field of regenerative medicine.
Please visit our Press Package for related press articles as well as our 2006 Safety and Efficacy Audit